News | February 08, 2022
AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
This is the ninth Covid-19 vaccine approved in India
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
DS-5670 is an mRNA vaccine against Covid-19 using a novel nucleic acid delivery technology discovered by the company
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
Previously, the use of the drug was limited to patients requiring hospitalization
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
Subscribe To Our Newsletter & Stay Updated
